Načítá se...
Screening the genome for HCC-specific CpG methylation signatures as biomarkers for diagnosis and prognosis evaluation
BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most common and invasive malignant tumors in the world. The change in DNA methylation is a key event in HCC. METHODS: Methylation datasets for HCC and 17 other types of cancer were downloaded from The Cancer Genome Atlas (TCGA). The CpG sites...
Uloženo v:
| Vydáno v: | BMC Med Genomics |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8214801/ https://ncbi.nlm.nih.gov/pubmed/34147096 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12920-021-01015-9 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|